Tuesday, April 21, 2020

Democrat Terror Caucus Uses Coronavirus to Lobby for Iran

The Terror Caucus puts Iran ahead of America.
On April 9th, as California passed 500 Wuhan Virus deaths and 19,000 cases, Senator Dianne Feinstein dispatched a letter on Senate stationary to the President of the United States.
The letter did not ask for help for California, but for Iran.
Senator Feinstein wrote to express her unhappiness that President Trump had blocked Iran from getting $5 billion from the International Monetary Fund. She urged him to help the Islamic terror state, which has murdered countless Americans, get the money in the "interests of international security"
While Americans were dying, the Senate Terror Caucus was hard at work… for Iran.
In late March, Connecticut's two Democrat Senate members, Chris Murphy and Dick Blumenthal, along with Hawaii's Schatz, Maryland's Van Hollen, New Mexico's Udall, Maryland's Cardin, Virginia's Kaine, Vermont's Leahy, Oregon's Merkley, Delaware's Carper, and Ohio’s Brown, had dispatched a letter to Secretary of State Mike Pompeo urging lowering economic sanctions on Iran and Venezuela while claiming that easing up on two terror states was “the right thing to do from a national security perspective.”
Two days earlier, Leahy, Udall, Carper, Brown, Merkeley, and Van Hollen had sent another letter to the Secretary of State on behalf of Hamas, claiming that “as of March 24, the first two cases of COVID-19 were confirmed in the Gaza Strip" and insisted that it is, “in the national security interest of the United States” to help the Hamas territory.
Joining the Tehran Six were Senator Elizabeth Warren and Senator Bernie Sanders.
The only reason Bernie Sanders hadn’t signed the Tehran Six letter was that he thought that it didn’t go far enough. Instead he joined Rep. Alexandria Ocasio-Cortez, Rep. Ilhan Omar, Rep. Rashida Tlaib, and other terrorist supporters in calling for a suspension of sanctions on Iran.
Read the rest from Daniel Greenfield HERE.

If you like what you see, please "Like" us on Facebook either here or here. Please follow us on Twitter here.

No comments: